The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by PEARSON MURPHY, B. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by PEARSON MURPHY, B. E.
Related Collections
* Neuroendocrinology
* Gender
* Panic Disorder
* Antidepressants
* Molecular Biology
Am J Psychiatry 160:593-594, March 2003
© 2003 American Psychiatric Association


Letter to the Editor

Neuroactive Steroid Levels in Patients With Panic Disorder

BEVERLEY E. PEARSON MURPHY, M.D., Ph.D.
Montreal, Que., Canada

To the Editor: I find the article by Andreas Ströhle, M.D., et al. (1) very puzzling. The authors studied seven women and three men with panic disorder and examined them in relation to 10 age- and sex-matched comparison subjects. The steroid levels were given as the mean and SD in nanomoles per liter, with the sexes combined.

We were not told in what phase of the menstrual cycle the women were studied; one must assume, since the SDs for the steroids were relatively small—implying that the values for men and women were similar—that the women must have been studied in the follicular phase of their cycles. Or perhaps some of them were postmenopausal, since the age range was quite wide (37.2 years, SD=10.2).

However, the levels of progesterone for the comparison subjects (24.1 nmol/liter, SD=2.6), and, indeed, for all the subjects, are clearly in the luteal range!—far above the well-established value of about 1 nmol/liter in men, in postmenopausal women, and in women in the follicular phase of the cycle (24). Luteal levels range from 6 to 64 nmol/liter. The research method used was gas chromatography/mass spectrometry; one was referred to a previous article by the same group (5). In that article, the mean level of progesterone in eight healthy comparison men was 7.2 nmol/ml, while the mean level of allopregnanolone was about 4 nmol/liter. The authors’ levels of these two steroids are thus inconsistent with their own previous data.

Their progesterone values are in serious disagreement with well-established data, obtained mostly through radioimmunoassay. Their values for almost all of the steroids measured are much higher than those found by a colleague and me by using a combination of high-performance liquid chromatography and radioimmunoassay (6). While gas chromatography/mass spectrometry holds great promise for providing more sensitive methods for detection of neuroactive steroids, which are present in very low concentrations in the blood, one cannot ignore the large differences in the results obtained to date that have not been explained.

References

  1. Ströhle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R: GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 2002; 159:145-157[Abstract/Free Full Text]
  2. Griffin JE, Wilson JD: Disorders of the testes and the male reproductive tract, in Williams Textbook of Endocrinology, 9th edition. Edited by Wilson JD, Foster DW. Philadelphia, WB Saunders, 1998, pp 819-875
  3. Fisher DA, Nelson JC: Endocrine testing, in Endocrinology, 3rd edition. Edited by DeGroot LJ, Jameson JL. Philadelphia, WB Saunders, 2001, p 2594
  4. Laposata M: The New England Journal of Medicine SI Unit Conversion Guide. Boston, NEJM Books, 1992, p 43
  5. Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R: Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998; 155:910-913[Abstract/Free Full Text]
  6. Pearson Murphy BE, Allison CM: Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. J Steroid Biochem Mol Biol 2000; 74:134-142




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by PEARSON MURPHY, B. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by PEARSON MURPHY, B. E.
Related Collections
* Neuroendocrinology
* Gender
* Panic Disorder
* Antidepressants
* Molecular Biology


Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org